Doximity's Q2 revenue soars 76% as company pegs valuation at nearly $14B

Doximity, a health tech company that claims to have more than 80% of doctors on its network, brought in $79 million in revenue in the second quarter, a 76% jump from the same period a year ago.

The company's adjusted EBITDA during the quarter came to $33 million versus $13 million, an increase of 160% year over year, representing adjusted EBITDA margins of 41%, versus 28%. For the third quarter, the company is projecting revenue between $86 million and $87 million. The company is projecting adjusted EBITDA for the full year between $128 million and $130 million.